Martin Nicklasson, Ph.D. joined the Board of Directors of POZEN in June 2011 and is a memeber of the Compensation Committee.
A nominee for election as a Class II director, has spent his career in the pharmaceutical industry, and has extensive experience in research and development, as well as marketing and business development. A certified pharmacist in Sweden who also holds a Ph.D. in pharmaceutical technology, Dr. Nicklasson spent most of his career at AstraZeneca in a variety of senior executive positions and was formerly president and chief operating officer of Swedish Orphan International Biovitrum AB, a publically listed specialty pharmaceutical company in Sweden.